Metabolic
Survodutide
Investigational dual glucagon / GLP-1 receptor agonist in late-stage trials for obesity and liver disease.
What is Survodutide?
Survodutide is a once-weekly peptide that activates both the glucagon and GLP-1 receptors. It is in phase 3 trials for obesity and for fatty liver disease.
It is not approved anywhere; products sold online are unregulated.
Before you buy
- A lab report for this exact batch (a Certificate of Analysis)
- A batch number on the vial that matches the report
- A sealed vial of freeze-dried powder, stored cold and away from light as the label requires
Informational summary only, not medical advice. Read the safety guide and consult a qualified healthcare professional.
0 offers
No products match these filters.
Try another delivery country or include all payment protection levels.
Prices are per pack in US dollars. You pay in cryptocurrency, and delivery is added before payment. How document checks work